Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

35321 - 35330 of 44979 results found

Evaluation of risk management in a natalizumab home infusion procedure

Date
Thursday, May 18, 2023 - 4:00 AM
Description
Natalizumab is a well-established disease-modifying therapy used in active multiple sclerosis (MS). The most serious adverse event is progressive multifocal leukoencephalopathy. For safety reasons, hospital implementation is mandatory. The SARS-CoV-2

SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic

Date
Thursday, May 18, 2023 - 4:00 AM
Description
CONCLUSION: During a period of partial opening during the COVID-19 pandemic in London, we detected SARS-CoV2 RNA in the air of hospital waiting areas and wards and of London Underground train carriage. More research is needed to determine the

Evaluating the impact of the COVID-19 related public health restrictions on access to digital sexually transmitted and blood borne infection testing in British Columbia, Canada: An interrupted time series analysis

Date
Wednesday, May 17, 2023 - 4:00 AM
Description
CONCLUSIONS: Sustained increases in utilization of digital STBBI testing during the pandemic suggest fundamental changes in STBBI testing in BC, highlighting the need for accessible and appropriate digital testing, especially for those most affected